Cellular and Molecular Immunology

, volume 17 , issue 6 , pages 647-649

Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor

Xiangyu Chen ¹

Ren Li ^{2, 3}

Zhiwei Pan ¹

Chunfang Qian ⁴

Yang Yang ¹

Renrong You ⁵

Jing Zhao ⁶

Pinghuang Liu ⁵

Leiqiong Gao ¹

Zhirong Li ¹

Qizhao Huang ⁷

Lifan Xu ¹

Jianfang Tang ¹

Qin Tian ¹

Wei Yao ¹

Li Hu ¹

Xiaofeng Yan ⁴

Xinyuan Zhou ¹

Yuzhang Wu ¹

Kai Deng ⁸

Zheng Zhang ⁹

Zhaohui Qian ¹⁰

Yaokai Chen ⁴

Lilin Ye ¹

Hide authors affiliations Show authors affiliations: 10 affiliations

Institute of Immunology, PLA, Third Military Medical University, Chongqing, China

Chongqing Medical University

Army Medical University

State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China |

College of Veterinary Medicine, Northeast Agricultural University, Harbin Heilongjiang, China |

⁴

Chongqing Public Health Medical Center, Chongqing, China |

⁵

Comparative Immunology Research Center, College of Veterinary Medicine, China Agricultural University, Beijing, China |

⁶

Biomedical Analysis Center, Third Military Medical University, Chongqing, China

Chongqing Medical University

Army Medical University

⁷

Cancer Center, The General Hospital of Western Theater Command, Chengdu, China |

⁸

Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China |

⁹

Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People’s Hospital, Shenzhen, China |

¹⁰

NHC Key laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China |

Publication type: Journal Article

Publication date: 2020-04-20

Springer Nature

Cellular and Molecular Immunology

scimago Q1

wos Q1

SJR: 5.916

CiteScore: 36.2

Impact factor: 19.8

ISSN: 16727681, 20420226

DOI: 10.1038/s41423-020-0426-7

Copy DOI

PubMed ID: 32313207

Infectious Diseases

Immunology

Immunology and Allergy

Found

1 citation

Ivanov Aleksandr

DSc in Biological/biomedical sciences

143 publications, 3 064 citations, 13 reviews

h-index: 25

Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences

Research interests

HIV

Reactive oxygen species

1 citation

Yusubalieva Gaukhar

🥼 🤝

PhD in Health sciences

84 publications, 925 citations

h-index: 16

Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences

Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency of Russia

Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies, FMBA of Russia

Research interests

Brain stem cells

CAR-NK cells

Experimental oncology

Immunotherapy

Oncolytic viruses

1 citation

Saxena Shailendra K

🥼 🤝

fellow of the Royal Society

224 publications, 3 798 citations, 6 reviews

h-index: 34

King George's Medical University

Top-30

Journals

	2 4 6 8 10
bioRxiv	bioRxiv, 10, 3.21% bioRxiv 10 publications, 3.21%
International Journal of Molecular Sciences	International Journal of Molecular Sciences, 9, 2.88% International Journal of Molecular Sciences 9 publications, 2.88%
Frontiers in Immunology	Frontiers in Immunology, 9, 2.88% Frontiers in Immunology 9 publications, 2.88%
Scientific Reports	Scientific Reports, 9, 2.88% Scientific Reports 9 publications, 2.88%
Cell Reports	Cell Reports, 7, 2.24% Cell Reports 7 publications, 2.24%
medRxiv : the preprint server for health sciences	medRxiv : the preprint server for health sciences, 6, 1.92% medRxiv : the preprint server for health sciences 6 publications, 1.92%
Viruses	Viruses, 5, 1.6% Viruses 5 publications, 1.6%
Signal Transduction and Targeted Therapy	Signal Transduction and Targeted Therapy, 5, 1.6% Signal Transduction and Targeted Therapy 5 publications, 1.6%
Computational and Structural Biotechnology Journal	Computational and Structural Biotechnology Journal, 4, 1.28% Computational and Structural Biotechnology Journal 4 publications, 1.28%
Immunity	Immunity, 4, 1.28% Immunity 4 publications, 1.28%
Journal of Clinical Medicine	Journal of Clinical Medicine, 3, 0.96% Journal of Clinical Medicine 3 publications, 0.96%
International Immunopharmacology	International Immunopharmacology, 3, 0.96% International Immunopharmacology 3 publications, 0.96%
PLoS Pathogens	PLoS Pathogens, 3, 0.96% PLoS Pathogens 3 publications, 0.96%
Journal of Biological Chemistry	Journal of Biological Chemistry, 3, 0.96% Journal of Biological Chemistry 3 publications, 0.96%
Angewandte Chemie	Angewandte Chemie, 3, 0.96% Angewandte Chemie 3 publications, 0.96%
Angewandte Chemie - International Edition	Angewandte Chemie - International Edition, 3, 0.96% Angewandte Chemie - International Edition 3 publications, 0.96%
Journal of Medical Virology	Journal of Medical Virology, 3, 0.96% Journal of Medical Virology 3 publications, 0.96%
Journal of Virology	Journal of Virology, 3, 0.96% Journal of Virology 3 publications, 0.96%
Science	Science, 2, 0.64% Science 2 publications, 0.64%
JCI insight	JCI insight, 2, 0.64% JCI insight 2 publications, 0.64%
Pharmaceutics	Pharmaceutics, 2, 0.64% Pharmaceutics 2 publications, 0.64%
Diagnostics	Diagnostics, 2, 0.64% Diagnostics 2 publications, 0.64%
Frontiers in Cell and Developmental Biology	Frontiers in Cell and Developmental Biology, 2, 0.64% Frontiers in Cell and Developmental Biology 2 publications, 0.64%
Frontiers in Molecular Biosciences	Frontiers in Molecular Biosciences, 2, 0.64% Frontiers in Molecular Biosciences 2 publications, 0.64%
3 Biotech	3 Biotech, 2, 0.64% 3 Biotech 2 publications, 0.64%
Archives of Virology	Archives of Virology, 2, 0.64% Archives of Virology 2 publications, 0.64%
Molecular Biomedicine	Molecular Biomedicine, 2, 0.64% Molecular Biomedicine 2 publications, 0.64%
Nature Reviews Immunology	Nature Reviews Immunology, 2, 0.64% Nature Reviews Immunology 2 publications, 0.64%
Acta Pharmacologica Sinica	Acta Pharmacologica Sinica, 2, 0.64% Acta Pharmacologica Sinica 2 publications, 0.64%
	2 4 6 8 10

Publishers

	10 20 30 40 50 60 70 80
Elsevier	Elsevier, 76, 24.36% Elsevier 76 publications, 24.36%
Cold Spring Harbor Laboratory	Cold Spring Harbor Laboratory, 61, 19.55% Cold Spring Harbor Laboratory 61 publications, 19.55%
Springer Nature	Springer Nature, 43, 13.78% Springer Nature 43 publications, 13.78%
Wiley	Wiley, 30, 9.62% Wiley 30 publications, 9.62%
MDPI	MDPI, 26, 8.33% MDPI 26 publications, 8.33%
Frontiers Media S.A.	Frontiers Media S.A., 16, 5.13% Frontiers Media S.A. 16 publications, 5.13%
American Chemical Society (ACS)	American Chemical Society (ACS), 7, 2.24% American Chemical Society (ACS) 7 publications, 2.24%
Taylor & Francis	Taylor & Francis, 6, 1.92% Taylor & Francis 6 publications, 1.92%
Oxford University Press	Oxford University Press, 6, 1.92% Oxford University Press 6 publications, 1.92%
American Society for Microbiology	American Society for Microbiology, 6, 1.92% American Society for Microbiology 6 publications, 1.92%
American Association for the Advancement of Science (AAAS)	American Association for the Advancement of Science (AAAS), 5, 1.6% American Association for the Advancement of Science (AAAS) 5 publications, 1.6%
Public Library of Science (PLoS)	Public Library of Science (PLoS), 5, 1.6% Public Library of Science (PLoS) 5 publications, 1.6%
American Society for Biochemistry and Molecular Biology	American Society for Biochemistry and Molecular Biology, 3, 0.96% American Society for Biochemistry and Molecular Biology 3 publications, 0.96%
Royal Society of Chemistry (RSC)	Royal Society of Chemistry (RSC), 3, 0.96% Royal Society of Chemistry (RSC) 3 publications, 0.96%
American Society for Clinical Investigation	American Society for Clinical Investigation, 2, 0.64% American Society for Clinical Investigation 2 publications, 0.64%
Rockefeller University Press	Rockefeller University Press, 2, 0.64% Rockefeller University Press 2 publications, 0.64%
Hindawi Limited	Hindawi Limited, 2, 0.64% Hindawi Limited 2 publications, 0.64%
Mary Ann Liebert	Mary Ann Liebert, 1, 0.32% Mary Ann Liebert 1 publication, 0.32%
PeerJ	PeerJ, 1, 0.32% PeerJ 1 publication, 0.32%
Portland Press	Portland Press, 1, 0.32% Portland Press 1 publication, 0.32%
Newlands Press Ltd	Newlands Press Ltd, 1, 0.32% Newlands Press Ltd 1 publication, 0.32%
Technosdar Ltd	Technosdar Ltd, 1, 0.32% Technosdar Ltd 1 publication, 0.32%
King Saud University	King Saud University, 1, 0.32% King Saud University 1 publication, 0.32%
SAGE	SAGE, 1, 0.32% SAGE 1 publication, 0.32%
Bentham Science Publishers Ltd.	Bentham Science Publishers Ltd., 1, 0.32% Bentham Science Publishers Ltd. 1 publication, 0.32%
Farname, Inc.	Farname, Inc., 1, 0.32% Farname, Inc. 1 publication, 0.32%
Heighten Science Publications Corporation	Heighten Science Publications Corporation, 1, 0.32% Heighten Science Publications Corporation 1 publication, 0.32%
eLife Sciences Publications	eLife Sciences Publications, 1, 0.32% eLife Sciences Publications 1 publication, 0.32%
	10 20 30 40 50 60 70 80

We do not take into account publications without a DOI.
Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

312

Cite this

GOST |

Cite this

GOST Copy

Chen X. et al. Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor // Cellular and Molecular Immunology. 2020. Vol. 17. No. 6. pp. 647-649.

GOST all authors (up to 50) Copy

Chen X., Li R., Pan Z., Qian C., Yang Y., You R., Zhao J., Liu P., Gao L., Li Z., Huang Q., Xu L., Tang J., Tian Q., Yao W., Hu L., Yan X., Zhou X., Wu Y., Deng K., Zhang Z., Qian Z., Chen Y., Ye L. Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor // Cellular and Molecular Immunology. 2020. Vol. 17. No. 6. pp. 647-649.

RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.1038/s41423-020-0426-7

UR - https://doi.org/10.1038/s41423-020-0426-7

TI - Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor

T2 - Cellular and Molecular Immunology

AU - Chen, Xiangyu

AU - Li, Ren

AU - Pan, Zhiwei

AU - Qian, Chunfang

AU - Yang, Yang

AU - You, Renrong

AU - Zhao, Jing

AU - Liu, Pinghuang

AU - Gao, Leiqiong

AU - Li, Zhirong

AU - Huang, Qizhao

AU - Xu, Lifan

AU - Tang, Jianfang

AU - Tian, Qin

AU - Yao, Wei

AU - Hu, Li

AU - Yan, Xiaofeng

AU - Zhou, Xinyuan

AU - Wu, Yuzhang

AU - Deng, Kai

AU - Zhang, Zheng

AU - Qian, Zhaohui

AU - Chen, Yaokai

AU - Ye, Lilin

PY - 2020

DA - 2020/04/20

PB - Springer Nature

SP - 647-649

IS - 6

VL - 17

PMID - 32313207

SN - 1672-7681

SN - 2042-0226

ER -

BibTex |

Cite this

BibTex (up to 50 authors) Copy

@article{2020_Chen,

author = {Xiangyu Chen and Ren Li and Zhiwei Pan and Chunfang Qian and Yang Yang and Renrong You and Jing Zhao and Pinghuang Liu and Leiqiong Gao and Zhirong Li and Qizhao Huang and Lifan Xu and Jianfang Tang and Qin Tian and Wei Yao and Li Hu and Xiaofeng Yan and Xinyuan Zhou and Yuzhang Wu and Kai Deng and Zheng Zhang and Zhaohui Qian and Yaokai Chen and Lilin Ye},

title = {Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor},

journal = {Cellular and Molecular Immunology},

year = {2020},

volume = {17},

publisher = {Springer Nature},

month = {apr},

url = {https://doi.org/10.1038/s41423-020-0426-7},

number = {6},

pages = {647--649},

doi = {10.1038/s41423-020-0426-7}

}

MLA

Cite this

MLA Copy

Chen, Xiangyu, et al. “Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor.” Cellular and Molecular Immunology, vol. 17, no. 6, Apr. 2020, pp. 647-649. https://doi.org/10.1038/s41423-020-0426-7.

Publisher

Springer Nature

Journal

Cellular and Molecular Immunology

scimago Q1

wos Q1

SJR

5.916

CiteScore

36.2

Impact factor

19.8

ISSN

16727681 (Print)

20420226 (Electronic)